ADVFN US – Market Content Editor
-
Ideaya Biosciences Shares Jump Following $210 Million Licensing Deal with Servier
Ideaya Biosciences Inc (NASDAQ:IDYA) saw its stock climb 6.9% in premarket trading on Tuesday after announcing an exclusive licensing agreement with French pharmaceutical company Servier for its eye cancer therapy, darovasertib. Under the agreement, Servier will gain regulatory and commercial rights for darovasertib in all territories outside the United States, while Ideaya retains U.S. rights.…
-
SHF Holdings Shares Surge After Launching Full-Service Cannabis Banking Program
SHF Holdings Inc (NASDAQ:SHFS) stock jumped 70% in premarket trading on Tuesday after unveiling its Fully Managed Cannabis Banking Program, a first-of-its-kind solution providing end-to-end operational and compliance outsourcing for financial institutions serving the cannabis industry. The program enables banks and credit unions to handle cannabis-related deposits without expanding internal teams or assuming additional regulatory…
-
Amarin Shares Rise on ESC Congress Data Highlighting VASCEPA Mechanism
Shares of Amarin Corporation PLC (NASDAQ:AMRN) increased 3.1% in premarket trading after the company presented new in vitro data at the European Society of Cardiology Congress 2025 showing potential anti-inflammatory mechanisms of its drug VASCEPA/VAZKEPA. The research highlighted how eicosapentaenoic acid (EPA), VASCEPA’s active ingredient, may help reduce inflammation in atherosclerotic cardiovascular disease (ASCVD) by…
-
TNF Pharmaceuticals Shares Rise After Gaining Exclusive Crypto Computing Rights
Shares of TNF Pharmaceuticals (NASDAQ:TNFA) climbed 5% following the announcement that the company has secured exclusive global rights to a pioneering light-based computing accelerator for cryptocurrency applications. The company entered into a licensing agreement with LightSolver Ltd. for its laser-based processing unit (LPU) technology, designed to execute compute-intensive operations far faster than conventional GPUs and…
-
Academy Sports and Outdoors Shares Fall After Q2 Earnings Miss Forecasts
Shares of Academy Sports and Outdoors (NASDAQ:ASO) slipped more than 7% in premarket trading on Tuesday after the retailer reported second-quarter results that came in below analyst expectations, despite recording positive comparable sales for the first time in several quarters. The sporting goods chain posted adjusted earnings per share of $1.94, missing the consensus estimate…
-
Constellation Brands shares drop after cutting full-year guidance
Shares of Constellation Brands (NYSE:STZ) fell 8% Tuesday morning following the company’s substantial reduction of its fiscal 2026 earnings forecast, citing a challenging macroeconomic backdrop that is weighing on consumer demand. The company now expects comparable earnings per share of $11.30-$11.60, significantly below its previous range of $12.60-$12.90 and analysts’ consensus of $12.66. Constellation also…
-
United Therapeutics shares surge after Tyvaso IPF trial hits key goal
Shares of United Therapeutics (NASDAQ:UTHR) jumped 54% following news that the company’s pivotal TETON-2 trial of Tyvaso for idiopathic pulmonary fibrosis (IPF) successfully achieved its primary endpoint. The study found that nebulized Tyvaso (treprostinil) Inhalation Solution significantly outperformed placebo, improving absolute forced vital capacity (FVC) by 95.6 mL (p<0.001). The treatment also demonstrated statistically significant…
-
Microsoft and GSA Strike Deal to Boost AI Integration in Federal Government
Microsoft (NASDAQ:MSFT) has entered into a sweeping agreement with the U.S. General Services Administration (GSA) aimed at accelerating the adoption of artificial intelligence, cloud, and productivity tools across federal agencies. As part of the deal, Microsoft will provide Microsoft 365 Copilot at no additional cost for up to a year to millions of current Microsoft…
-
Universal Safety Products Shares Surge on $1 Special Dividend Announcement
Universal Safety Products, Inc. (AMEX:UUU) shares skyrocketed 60% in early Tuesday trading after the company declared a one-time special cash dividend of $1.00 per common share. The dividend will be distributed on September 25, 2025, to investors holding shares as of September 18, 2025. The move comes after the company’s successful asset sale to Feit…
-
Ionis Shares Surge on Strong Phase 3 Data for Olezarsen
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) jumped 22% on Tuesday after unveiling highly positive topline results from its pivotal Phase 3 CORE and CORE2 trials evaluating olezarsen in patients with severe hypertriglyceridemia (sHTG). The therapy not only lowered fasting triglyceride levels by as much as 72% versus placebo, but also achieved an 85% reduction in acute pancreatitis…